Paper15752
Clinical pharmacokinetics of sulphasalazine.
Das KM and 1 other. Clin Pharmacokinet, 1976. Cited by 184 papers, by iCite.
Cite this record
ConductScience Library. Clinical pharmacokinetics of sulphasalazine. Papers, record 15752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sulfasalazine | Major topic |
| Acetylation | |
| Animals | |
| Anti-Bacterial Agents | |
| Binding, Competitive | |
| Calcium | |
| Drug Interactions | |
| Folic Acid | |
| Humans | |
| Intestinal Absorption | |
| Iron | |
| Kinetics | |
| Phenobarbital | |
| Phenotype | |
| Protein Binding | |
| Time Factors |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13952555 | Distribution and metabolism of salicyl-azo-sulfapyridine. I. A study with C-14-5-amino-salicylic acid. | Acta Med Scand | 1963 | https://conductscience.org/library/papers/13952555 | PubMed |
| 2 | 4400659 | [Treatment of radiation proctitis]. | Geburtshilfe Frauenheilkd | 1971 | https://conductscience.org/library/papers/4400659 | PubMed |
| 3 | 4144775 | Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). | Gastroenterology | 1973 | https://conductscience.org/library/papers/4144775 | PubMed |
| 4 | 13994348 | Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. | Br Med J | 1962 | https://conductscience.org/library/papers/13994348 | PubMed |
| 6 | 4146457 | Salicylazosulfapyridine in clinical practice. | Gastroenterology | 1973 | https://conductscience.org/library/papers/4146457 | PubMed |
| 7 | 4155692 | Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. | Gut | 1974 | https://conductscience.org/library/papers/4155692 | PubMed |
| 8 | 4824571 | Respiratory disease due to sulphasalazine. | Clin Allergy | 1974 | https://conductscience.org/library/papers/4824571 | PubMed |
| 9 | 4402886 | Absorption, metabolism, and excretion of salicylazosulfapyridine in man. | Clin Pharmacol Ther | 1972 | https://conductscience.org/library/papers/4402886 | PubMed |
| 10 | 13952556 | Distribution and metabolism of salicyl-azo-sulfapyridine. II. A study with S35-salicyl-azo-sulfapyridine and S35-sulfapyridine. | Acta Med Scand | 1963 | https://conductscience.org/library/papers/13952556 | PubMed |
| 11 | 4393788 | Neurotoxicity associated with a reaction to sulphasalazine. | Practitioner | 1970 | https://conductscience.org/library/papers/4393788 | PubMed |
| 12 | 4151092 | Agranulocytosis associated with sulphasalazine therapy. | Postgrad Med J | 1973 | https://conductscience.org/library/papers/4151092 | PubMed |
| 13 | 4144706 | Effect of iron and calcium on salicylazosulphapyridine metabolism. | Scott Med J | 1973 | https://conductscience.org/library/papers/4144706 | PubMed |
| 14 | 13722334 | Peripheral neuritis due to isoniazid. | Bull World Health Organ | 1960 | https://conductscience.org/library/papers/13722334 | PubMed |
| 16 | 4152289 | Fibrosing alveolitis and treatment with sulphasalazine. | Gut | 1974 | https://conductscience.org/library/papers/4152289 | PubMed |
| 17 | 4146729 | Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4146729 | PubMed |
| 18 | 4402071 | Ulcerative postdysenteric colitis. | Am J Gastroenterol | 1972 | https://conductscience.org/library/papers/4402071 | PubMed |
| 19 | 13760840 | An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis. | Gut | 1960 | https://conductscience.org/library/papers/13760840 | PubMed |
| 20 | 5500003 | The metabolism of azo compounds: a review of the literature. | Food Cosmet Toxicol | 1970 | https://conductscience.org/library/papers/5500003 | PubMed |
| 21 | 4386858 | Unusual cause of yellow skin. | Br Med J | 1968 | https://conductscience.org/library/papers/4386858 | PubMed |
| 22 | 235486 | Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis. | Gut | 1975 | https://conductscience.org/library/papers/235486 | PubMed |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 184 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41675296 | Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase, unblinded, single-arm, proof of concept clinical trial. | EClinicalMedicine | 2026 | https://conductscience.org/library/papers/41675296 | PubMed |
| 39598554 | Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39598554 | PubMed |
| 39329122 | Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39329122 | PubMed |
| 38230664 | The aminosalicylate - folate connection. | Drug Metab Rev | 2024 | https://conductscience.org/library/papers/38230664 | PubMed |
| 37835065 | Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections. | J Clin Med | 2023 | https://conductscience.org/library/papers/37835065 | PubMed |
| 37160525 | Therapeutic drug monitoring of disease-modifying antirheumatic drugs in circulating leukocytes in immune-mediated inflammatory diseases. | Inflammopharmacology | 2023 | https://conductscience.org/library/papers/37160525 | PubMed |
| 34734308 | Immunosuppression in Rheumatologic and Auto-immune Disease. | Handb Exp Pharmacol | 2022 | https://conductscience.org/library/papers/34734308 | PubMed |
| 33671835 | Quantification and Metabolite Identification of Sulfasalazine in Mouse Brain and Plasma Using Quadrupole-Time-of-Flight Mass Spectrometry. | Molecules | 2021 | https://conductscience.org/library/papers/33671835 | PubMed |
| 32658475 | The Structural Basis for Nonsteroidal Anti-Inflammatory Drug Inhibition of Human Dihydrofolate Reductase. | J Med Chem | 2020 | https://conductscience.org/library/papers/32658475 | PubMed |
| 32157196 | Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/32157196 | PubMed |
| 29556907 | Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview. | Adv Ther | 2018 | https://conductscience.org/library/papers/29556907 | PubMed |
| 25980667 | Pharmacogenetics of treatment response in psoriatic arthritis. | Curr Rheumatol Rep | 2015 | https://conductscience.org/library/papers/25980667 | PubMed |
| 24892773 | PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. | Pharmacogenet Genomics | 2014 | https://conductscience.org/library/papers/24892773 | PubMed |
| 24734245 | Digging up the human genome: current progress in deciphering adverse drug reactions. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/24734245 | PubMed |
| 24394199 | Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis. | Pharmacogenomics J | 2014 | https://conductscience.org/library/papers/24394199 | PubMed |
| 19369484 | Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia. | Mol Pharmacol | 2009 | https://conductscience.org/library/papers/19369484 | PubMed |
| 15032315 | N-acetyltransferase 2 genotype-related efficacy of sulfasalazine in patients with rheumatoid arthritis. | Pharm Res | 2004 | https://conductscience.org/library/papers/15032315 | PubMed |
| 14722200 | Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs. | Ann Rheum Dis | 2004 | https://conductscience.org/library/papers/14722200 | PubMed |
| 11990379 | Pharmacogenetics of the arylamine N-acetyltransferases. | Pharmacogenomics J | 2002 | https://conductscience.org/library/papers/11990379 | PubMed |
| 8617147 | Pleuropericarditis related to the use of mesalamine. | Dig Dis Sci | 1996 | https://conductscience.org/library/papers/8617147 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15752
GET https://conductscience.org/api/papers/v1/15752/references?page=2